share_log

DermTech Analyst Ratings

DermTech Analyst Ratings

DermTech 分析師評級
Benzinga ·  2023/08/07 23:00
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/07/2023 85.19% BTIG $6 → $5 Maintains Buy
03/29/2023 122.22% TD Cowen $8 → $6 Maintains Outperform
11/09/2022 85.19% Stephens & Co. $16 → $5 Maintains Overweight
11/08/2022 122.22% BTIG $15 → $6 Maintains Buy
11/04/2022 William Blair Downgrades Outperform → Market Perform
08/17/2022 751.85% Oppenheimer $48 → $23 Maintains Outperform
08/15/2022 455.56% BTIG $19 → $15 Maintains Buy
07/18/2022 1677.78% Oppenheimer → $48 Assumes → Outperform
01/07/2022 Stephens & Co. Initiates Coverage On → Overweight
05/03/2021 1862.96% BTIG → $53 Initiates Coverage On → Buy
01/22/2021 1862.96% Oppenheimer → $53 Initiates Coverage On → Outperform
10/30/2020 William Blair Initiates Coverage On → Outperform
09/10/2020 640.74% Cowen & Co. → $20 Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
08/07/2023 85.19% BTIG $6→$5 維護
03/29/2023 122.22% TD Cowen $8→$6 維護 跑贏大盤
11/09/2022 85.19% 斯蒂芬斯公司 $16→$5 維護 超重
11/08/2022 122.22% BTIG $15→$6 維護
11/04/2022 - 威廉·布萊爾 評級下調 跑贏→市場表現
2022/08/17 751.85% 奧本海默 $48→$23 維護 跑贏大盤
2022年08月15日 455.56% BTIG $19→$15 維護
07/18/2022 1677.78% 奧本海默 →$48 假設 →跑贏大盤
01/07/2022 - 斯蒂芬斯公司 開始承保 →超重
05/03/2021 1862.96% BTIG →$53 開始承保 →購買
2021/01/22 1862.96% 奧本海默 →$53 開始承保 →跑贏大盤
10/30/2020 - 威廉·布萊爾 開始承保 →跑贏大盤
09/10/2020 640.74% 考恩公司 →$20 開始承保 →跑贏大盤

What is the target price for DermTech (DMTK)?

德美科技(DMTK)的目標價是多少?

The latest price target for DermTech (NASDAQ: DMTK) was reported by BTIG on August 7, 2023. The analyst firm set a price target for $5.00 expecting DMTK to rise to within 12 months (a possible 85.19% upside). 7 analyst firms have reported ratings in the last year.

德美科技(納斯達克:DMTK)的最新目標價是由BTIG於2023年8月7日報道的。這家分析公司將目標價定為5美元,預計DMTK將在12個月內上漲至85.19%(可能上漲85.19%)。去年有7家分析公司公佈了評級。

What is the most recent analyst rating for DermTech (DMTK)?

DemTech(DMTK)的最新分析師評級是多少?

The latest analyst rating for DermTech (NASDAQ: DMTK) was provided by BTIG, and DermTech maintained their buy rating.

德美泰克(納斯達克代碼:DMTK)的最新分析師評級由巴克萊資本提供,德美泰克維持買入評級。

When is the next analyst rating going to be posted or updated for DermTech (DMTK)?

DemTech(DMTK)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DermTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DermTech was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與DermTech的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。DermTech的上一次評級是在2023年8月7日提交的,所以你應該預計下一次評級將在2024年8月7日左右的某個時候公佈。

Is the Analyst Rating DermTech (DMTK) correct?

分析師對德美科技(DMTK)的評級正確嗎?

While ratings are subjective and will change, the latest DermTech (DMTK) rating was a maintained with a price target of $6.00 to $5.00. The current price DermTech (DMTK) is trading at is $2.70, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但最新的DermTech(DMTK)評級維持不變,目標價在6.00美元至5.00美元之間。德美科技(DMTK)目前的股價為2.70美元,超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論